More Americans want to work into their 70s. Smart companies will work with them.
Original Report
Many companies invest in early-career development but neglect retaining institutional knowledge at the other end of the career spectrum
Glass House Analysis
This story reflects the interconnected nature of modern economic systems, where developments in one sector inevitably affect others. Understanding these connections is essential for grasping how policy decisions and market movements translate into real-world outcomes for families, workers, and communities. The economy is not an abstract system of numbers—it's the sum total of decisions about who works, who prospers, and who struggles.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Column: Jensen Huang doesn’t need a new chip. He needs a new moat.
Jensen Huang is building a new moat with open-source AI — not out of generosity, but necessity, our tech columnist writes.
Trump signals DOJ should continue Powell probe, complicating Warsh Fed nom
Powell has accused the DOJ of investigating him in retaliation for his refusal to lower interest rates as much or as quickly as Trump has demanded.
Iran-induced fertilizer shortage threatens Republicans in farm states ahead of midterms
Democrats are vying for competitive seats across farm country in 2026, and fertilizer shortages spurred by the Iran war give them a new affordability angle.
A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved
Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.